Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Parathyroid Neoplasms × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 17 Neoplasms 9 Polycystic Ovary Syndrome 7 Multiple Myeloma 4 Vomiting 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity 2 Nausea 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Leukemia 2 Leiomyoma 2 Insulin Resistance 2 Inflammation 2 Infertility, Female 2 Glioblastoma 2 Colorectal Neoplasms 2 Cardiotoxicity 2 Carcinoma, Non-Small-Cell Lung 2 Weight Gain 1

Interventions

Parathyroidectomy 4 Cinacalcet 3 fluorocholine 2 belinostat 2 Trastuzumab 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Denosumab 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tipifarnib 1 lutetium Lu 177 dotatate 1 gallium Ga 68 dotatate 1 fluorodopa F 18 1 evocalcet 1 entinostat 1 acetaminophen, codeine drug combination 1 Tramadol 1 Tablets 1 Specimen Handling 1 Sodium Chloride 1 Rubidium-82 1 Ritonavir 1 Radiotherapy 1 Ipilimumab 1 Interleukin-12 Subunit p35 1 Interleukin-12 1 Indinavir 1 Gefitinib 1 Fluorouracil 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03027557 2021-05-25

DENOCINA

Aalborg University Hospital

Phase 3 Completed

46 enrolled 49 charts

Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡